Brigette Roberts's most recent trade in Quince Therapeutics Inc was a trade of 6,837,319 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 18, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Quince Therapeutics Inc | Brigette Roberts | Director, Chief Corp. Affairs Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2026 | 6,837,319 | 6,837,319 | - | - | Employee Stock Option (Right to Buy) | |
| Quince Therapeutics Inc | Brigette Roberts | Director, Chief Corp. Affairs Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2026 | 6,837,319 | 6,837,319 | - | - | Employee Stock Option (Right to Buy) | |
| Quince Therapeutics Inc | Brigette Roberts | Director, Chief Corp. Affairs Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2026 | 2,070,107 | 2,070,107 | - | - | Employee Stock Option (Right to Buy) | |
| Quince Therapeutics Inc | Brigette Roberts | Director, Chief Corp. Affairs Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2026 | 362,092 | 362,092 | - | - | Employee Stock Option (Right to Buy) | |
| Quince Therapeutics Inc | Brigette Roberts | Director, Chief Corp. Affairs Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2026 | 228,855 | 228,855 | - | - | Employee Stock Option (Right to Buy) | |
| Quince Therapeutics Inc | Brigette Roberts | Director, Chief Corp. Affairs Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2026 | 133,615 | 133,615 | - | - | Employee Stock Option (Right to Buy) | |
| Quince Therapeutics Inc | Brigette Roberts | Director, Chief Corp. Affairs Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2026 | 124,830 | 124,830 | - | - | Employee Stock Option (Right to Buy) | |
| Quince Therapeutics Inc | Brigette Roberts | Director, Chief Corp. Affairs Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2026 | 69,350 | 69,350 | - | - | Employee Stock Option (Right to Buy) | |
| Quince Therapeutics Inc | Brigette Roberts | Director, Chief Corp. Affairs Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2026 | 34,675 | 34,675 | - | - | Employee Stock Option (Right to Buy) |